304 related articles for article (PubMed ID: 24619558)
1. Intracellular Signaling Pathways in Rheumatoid Arthritis.
Malemud CJ
J Clin Cell Immunol; 2013 Aug; 4():160. PubMed ID: 24619558
[TBL] [Abstract][Full Text] [Related]
2. Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways.
Ibrahim SSA; Huttunen KM
Inflammopharmacology; 2021 Aug; 29(4):965-974. PubMed ID: 33740220
[TBL] [Abstract][Full Text] [Related]
3. Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis.
Malemud CJ
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245561
[TBL] [Abstract][Full Text] [Related]
4. The role of the JAK/STAT signal pathway in rheumatoid arthritis.
Malemud CJ
Ther Adv Musculoskelet Dis; 2018 Jun; 10(5-6):117-127. PubMed ID: 29942363
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs.
Malemud CJ; Miller AH
Expert Opin Ther Targets; 2008 Feb; 12(2):171-83. PubMed ID: 18208366
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway.
Malemud CJ
Pharmaceuticals (Basel); 2010 May; 3(5):1446-1455. PubMed ID: 27713312
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase small molecule inhibitors for rheumatoid arthritis: Medicinal chemistry/clinical perspectives.
Malemud CJ; Blumenthal DE
World J Orthop; 2014 Sep; 5(4):496-503. PubMed ID: 25232525
[TBL] [Abstract][Full Text] [Related]
8. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
[TBL] [Abstract][Full Text] [Related]
9. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
Emori T; Kasahara M; Sugahara S; Hashimoto M; Ito H; Narumiya S; Higashi Y; Fujii Y
Eur J Pharmacol; 2020 Sep; 882():173238. PubMed ID: 32561292
[TBL] [Abstract][Full Text] [Related]
10. Dysfunctional Immune-Mediated Inflammation in Rheumatoid Arthritis Dictates that Development of Anti-Rheumatic Disease Drugs Target Multiple Intracellular Signaling Pathways.
Malemud CJ
Antiinflamm Antiallergy Agents Med Chem; 2011; 10(2):78-84. PubMed ID: 25182056
[TBL] [Abstract][Full Text] [Related]
11. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G
Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt.
Hashiramoto A; Sakai C; Yoshida K; Tsumiyama K; Miura Y; Shiozawa K; Nose M; Komai K; Shiozawa S
Arthritis Rheum; 2007 Jul; 56(7):2170-9. PubMed ID: 17599743
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.
Migita K; Izumi Y; Torigoshi T; Satomura K; Izumi M; Nishino Y; Jiuchi Y; Nakamura M; Kozuru H; Nonaka F; Eguchi K; Kawakami A; Motokawa S
Clin Exp Immunol; 2013 Dec; 174(3):356-63. PubMed ID: 23968543
[TBL] [Abstract][Full Text] [Related]
14. Follistatin-like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK/STAT3 and NF-κB pathways.
Ni S; Li C; Xu N; Liu X; Wang W; Chen W; Wang Y; van Wijnen AJ
J Cell Physiol; 2018 Jan; 234(1):454-463. PubMed ID: 29932210
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of long noncoding RNA LOC101928134 inhibits the synovial hyperplasia and cartilage destruction of osteoarthritis rats through the activation of the Janus kinase/signal transducers and activators of transcription signaling pathway by upregulating IFNA1.
Yang DW; Zhang X; Qian GB; Jiang MJ; Wang P; Wang KZ
J Cell Physiol; 2019 Jul; 234(7):10523-10534. PubMed ID: 30456844
[TBL] [Abstract][Full Text] [Related]
16. Genkwanin ameliorates adjuvant-induced arthritis in rats through inhibiting JAK/STAT and NF-κB signaling pathways.
Bao Y; Sun YW; Ji J; Gan L; Zhang CF; Wang CZ; Yuan CS
Phytomedicine; 2019 Oct; 63():153036. PubMed ID: 31401534
[TBL] [Abstract][Full Text] [Related]
17. Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement.
Orsolini G; Bertoldi I; Rossini M
Clin Rheumatol; 2020 Mar; 39(3):727-736. PubMed ID: 31970549
[TBL] [Abstract][Full Text] [Related]
18. Allylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 Pathways.
De S; Manna A; Kundu S; De Sarkar S; Chatterjee U; Sen T; Chattopadhyay S; Chatterjee M
J Pharmacol Exp Ther; 2017 Feb; 360(2):249-259. PubMed ID: 27856937
[TBL] [Abstract][Full Text] [Related]
19. Protein kinases in chondrocyte signaling and osteoarthritis.
Malemud CJ
Clin Orthop Relat Res; 2004 Oct; (427 Suppl):S145-51. PubMed ID: 15480058
[TBL] [Abstract][Full Text] [Related]
20. Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation.
Zhou JJ; Ma JD; Mo YQ; Zheng DH; Chen LF; Wei XN; Dai L
Arthritis Res Ther; 2014 Oct; 16(5):472. PubMed ID: 25367151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
